Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: Am J Health Syst Pharm. 2013 Mar 1;70(5):439–442. doi: 10.2146/ajhp110632

Figure 2.

Figure 2

Representative HPLC chromatograms of alemtuzumab stability study

(A): Blank, 0.9% Sodium Chloride injection, USP.

(B): Alemtuzumab reference solution.

(C): Alemtuzumab solution, 40 mcg/ml at time zero.

(D): Alemtuzumab solution, 40 mcg/ml at time 24 hours.